RAD51 INHIBITORS
This application is directed to inhibitors of RAD51 represented by the following structural formula,and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LAPIERRE, Jean-Marc MCCOMAS, Casey Cameron VACCA, Joseph |
| description | This application is directed to inhibitors of RAD51 represented by the following structural formula,and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022259198A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022259198A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022259198A13</originalsourceid><addsrcrecordid>eNrjZBAIcnQxNVTw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGRkamloaWFo6GxsSpAgBnSB5T</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RAD51 INHIBITORS</title><source>esp@cenet</source><creator>LAPIERRE, Jean-Marc ; MCCOMAS, Casey Cameron ; VACCA, Joseph</creator><creatorcontrib>LAPIERRE, Jean-Marc ; MCCOMAS, Casey Cameron ; VACCA, Joseph</creatorcontrib><description>This application is directed to inhibitors of RAD51 represented by the following structural formula,and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=US&NR=2022259198A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=US&NR=2022259198A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAPIERRE, Jean-Marc</creatorcontrib><creatorcontrib>MCCOMAS, Casey Cameron</creatorcontrib><creatorcontrib>VACCA, Joseph</creatorcontrib><title>RAD51 INHIBITORS</title><description>This application is directed to inhibitors of RAD51 represented by the following structural formula,and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAIcnQxNVTw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgZGRkamloaWFo6GxsSpAgBnSB5T</recordid><startdate>20220818</startdate><enddate>20220818</enddate><creator>LAPIERRE, Jean-Marc</creator><creator>MCCOMAS, Casey Cameron</creator><creator>VACCA, Joseph</creator><scope>EVB</scope></search><sort><creationdate>20220818</creationdate><title>RAD51 INHIBITORS</title><author>LAPIERRE, Jean-Marc ; MCCOMAS, Casey Cameron ; VACCA, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022259198A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>LAPIERRE, Jean-Marc</creatorcontrib><creatorcontrib>MCCOMAS, Casey Cameron</creatorcontrib><creatorcontrib>VACCA, Joseph</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAPIERRE, Jean-Marc</au><au>MCCOMAS, Casey Cameron</au><au>VACCA, Joseph</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RAD51 INHIBITORS</title><date>2022-08-18</date><risdate>2022</risdate><abstract>This application is directed to inhibitors of RAD51 represented by the following structural formula,and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2022259198A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | RAD51 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A20%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAPIERRE,%20Jean-Marc&rft.date=2022-08-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022259198A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |